But the issue with CRISPR is that it's been a slow rollout, and its business continues to incur significant losses. Is it ...
Advocates stress that while gene therapy is causing a buzz in wealthy countries, African governments must prioritise ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results